Status:
UNKNOWN
Hypercoagulability and Thromboembolic Risk in Patients With Malignant Disease, Evaluated by Thrombelastograph (TEG®)
Lead Sponsor:
Rigshospitalet, Denmark
Conditions:
Cancer
Eligibility:
All Genders
18+ years
Brief Summary
Patients with malignancies are at high risk of developing a thromboembolic complication and their treatment with chemo- and or radiation therapy further enhances this risk. Conventional haemostatic t...
Eligibility Criteria
Inclusion
- Clinical diagnosis of cancer
Exclusion
- Mamma cancer
Key Trial Info
Start Date :
November 1 2006
Trial Type :
OBSERVATIONAL
End Date :
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT00400504
Start Date
November 1 2006
Last Update
November 17 2006
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rigshospitalet
Copenhagen, Copenhagen, Denmark, DK-2100